1. Amgen Inc. (28 from 1,970 patents)

2. Merck + Co., Inc. (3 from 4,770 patents)

3. Amgem Inc. (1 from 1 patent)

1. 12214051 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

2. 11732266 - RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

3. 10905772 - Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)

4. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

5. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

6. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use

7. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

8. 9296698 - Amino heteroaryl compounds as beta-secretase modulators and methods of use

9. 9296759 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

10. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

11. 9012446 - Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use

12. 8921363 - Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors

13. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use

14. 8822485 - Amino heteroaryl compounds as beta-secretase modulators and methods of use

15. 8735384 - Amino heteroaryl compounds as beta-secretase modulators and methods of use